| Literature DB >> 32694198 |
Arash Akbarzadeh1,2, Aimee Lee S Houde2,3, Ben J G Sutherland2, Oliver P Günther4, Kristina M Miller5.
Abstract
Identifying early gene expression responses to hypoxia (i.e., low dissolved oxygen) as a tool to assess the degree of exposure to this stressor is crucial for salmonids, because they are increasingly exposed to hypoxic stress due to anthropogenic habitat change, e.g., global warming, excessive nutrient loading, and persistent algal blooms. Our goal was to discover and validate gill gene expression biomarkers specific to the hypoxia response in salmonids across multi-stressor conditions. Gill tissue was collected from 24 freshwater juvenile Chinook salmon (Oncorhynchus tshawytscha), held in normoxia [dissolved oxygen (DO) > 8 mg L-1] and hypoxia (DO = 4‒5 mg L-1) in 10 and 18° temperatures for up to six days. RNA-sequencing (RNA-seq) was then used to discover 240 differentially expressed genes between hypoxic and normoxic conditions, but not affected by temperature. The most significantly differentially expressed genes had functional roles in the cell cycle and suppression of cell proliferation associated with hypoxic conditions. The most significant genes (n = 30) were selected for real-time qPCR assay development. These assays demonstrated a strong correlation (r = 0.88; P < 0.001) between the expression values from RNA-seq and the fold changes from qPCR. Further, qPCR of the 30 candidate hypoxia biomarkers was applied to an additional 322 Chinook salmon exposed to hypoxic and normoxic conditions to reveal the top biomarkers to define hypoxic stress. Multivariate analyses revealed that smolt stage, water salinity, and morbidity status were relevant factors to consider with the expression of these genes in relation to hypoxic stress. These hypoxia candidate genes will be put into application screening Chinook salmon to determine the identity of stressors impacting the fish.Entities:
Keywords: RNA-seq,; gene expression; hypoxia biomarkers; microfluidics qPCR; oxygen
Mesh:
Substances:
Year: 2020 PMID: 32694198 PMCID: PMC7466982 DOI: 10.1534/g3.120.401487
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Technical road map of the experimental methods used for discovery (RNA-seq) and validation (q-PCR) of hypoxia biomarkers. Juvenile Chinook salmon were exposed to 18 possible water treatments in 30 L pot tanks (circles): three salinities (FW at 0 PSU, brackish (BW) at 20 PSU, and SW at 28 or 29 PSU), three temperatures (10, 14, and 18°C), and two dissolved oxygen (DO) concentrations (hypoxia 4‒5 mg L-1 and normoxia > 8 mg L-1) in all combinations, each in two replicates. Four trials were conducted over the smoltification period, covering pre-smolt (March), smolt (May), and de-smolt 1 (June) and de-smolt 2 (August) stages. A subset of 24 FW individuals kept at two temperatures (10°C and 18°C) and two DO conditions (normoxia and hypoxia) was selected for RNA-seq from the two de-smolt trials (trials 3 and 4). A group of 212 live-sampled (no signs of morbidity), and 88 distressed juveniles (moribund and recently dead) from the four trials exposed to the full treatment were used for qRT-PCR. Twenty two individuals from two SW/18°C-hypoxia tanks in the trial 3 had lower DO than intended in the SW treatment (3.3–4.1 mg L-1 instead of 4–5 mg L-1), and therefore were used as an ‘extreme hypoxia’ condition.
Figure 2Multi-dimensional scaling (MDS) plot to evaluate the effects of different factors (i.e., temperature, hypoxia, trial) on overall gene expression (3= trial 3, de-smolt; 4= trial 4, de-smolt).
Figure 3Canonical plot of the first two principal components of 240 candidate gill hypoxia genes.
Top 20 downregulated and 10 upregulated candidate genes from the RNA-seq analysis, and efficiencies for candidate hypoxia stress genes. Genes are presented in order of the significance of the correlation with PC1, which separated normoxia and hypoxia (data are in Table S1). Species abbreviations for efficieny: CK= Chinook salmon (Oncorhynchus tshawytscha), CO= Coho salmon (O. kisutch), CM= Chum salmon (O. keta), PK= Pink salmon (O. gorbuscha), SX= Sockeye salmon (O. nerka), AS= Atlantic salmon (Salmo salar), AC= Artic charr (Salvelinus alpinus), RT= Rainbow trout (O. mykiss), and BT= Bull trout (Salvelinus confluentus)
| Gene name | Function of gene | Assay name | PCR Efficiency | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CK | CO | CM | PK | SX | AS | AC | RT | BT | |||
| Anillin-like | Cell division | Anillin | 1.20 | 1.30 | 1.27 | 1.20 | 1.12 | 1.29 | 1.00 | 0.99 | 1.56 |
| Ribonucleoside-diphosphate reductase subunit M2-like | DNA synthesis | RRM2 | 1.28 | 1.38 | 1.27 | 1.07 | 1.15 | 1.34 | 1.10 | 1.00 | 1.47 |
| Aurora kinase B-like | Cell division | AURKB | 1.26 | 1.42 | 1.29 | 1.14 | 1.21 | 1.37 | 1.00 | 1.07 | 1.50 |
| Ribonucleoside-diphosphate reductase large subunit-like | DNA synthesis | RRM1 | 1.04 | 1.16 | 1.16 | 0.99 | 1.10 | 1.19 | 1.02 | 1.00 | 1.31 |
| Kinesin-like protein KIF2C | Cell division | KIF2C | 1.11 | 1.20 | 1.18 | 1.09 | 1.05 | 1.24 | 0.98 | 1.02 | 1.27 |
| Non-SMC condensin II complex subunit D3 | Cell division | Ncapd3 | 1.09 | 1.19 | 1.11 | 1.08 | 1.01 | 1.17 | 0.99 | 1.00 | 1.33 |
| Histone H2A.V | Cell division | H2AFV | 1.08 | 1.22 | 1.29 | 1.11 | 1.05 | 1.31 | 1.00 | 1.05 | 0.71 |
| Kinesin family member 15-like | Cell division | Kif15 | 1.17 | 1.22 | 1.15 | 1.01 | 1.03 | 1.21 | 0.99 | 1.02 | 1.31 |
| Rho GTPase-activating protein 11A-like | Cell division | ARHGAP11A | 1.22 | 1.28 | 1.20 | 1.03 | 1.10 | 1.33 | 1.05 | 0.98 | 1.42 |
| Rab9 effector protein with kelch motifs-like | Cell division | Rab9 | 1.26 | 1.16 | 1.26 | 1.03 | 1.05 | 1.08 | 1.02 | 1.03 | 1.03 |
| ERCC excision repair 6 like, spindle assembly checkpoint helicase | Cell division | ERCC6L | 1.13 | 1.22 | 1.18 | 1.10 | 1.06 | 1.16 | 1.02 | 1.01 | 1.29 |
| Tonsoku-like protein | DNA synthesis | Tonsl | 1.15 | 1.39 | 1.26 | 1.03 | 1.13 | 1.30 | 1.02 | 0.86 | 1.52 |
| Citron Rho-interacting kinase-like | Cell division | CIT | 1.16 | 1.28 | 1.14 | 1.10 | 1.08 | 1.21 | 1.01 | 1.02 | 1.38 |
| Proliferating cell nuclear antigen | DNA synthesis | PCNA | 1.11 | 1.20 | 1.12 | 1.11 | 1.26 | 1.17 | 1.04 | 0.99 | 1.26 |
| Claspin-like | DNA synthesis | Claspin | 1.16 | 1.25 | 1.04 | 1.03 | 1.04 | 1.15 | 0.81 | 0.93 | 1.18 |
| NDC80, kinetochore complex component | Cell division | Ndc80 | 1.13 | 1.25 | 1.21 | 1.03 | 0.99 | 1.19 | 1.01 | 0.99 | 1.30 |
| Lamin B1 | Cell division | Lmnb1 | 1.22 | 1.33 | 1.22 | 1.06 | 1.10 | 1.27 | 1.00 | 1.03 | 1.45 |
| Condensin-2 complex subunit G2-like | Cell division | NCAPG2 | 1.21 | 1.17 | — | 1.31 | — | 1.70 | 1.20 | 0.99 | 1.36 |
| Chromosome-associated kinesin KIF4-like | Cell division | Kif4 | 1.28 | 1.24 | 1.35 | 1.01 | 1.06 | 1.28 | 1.13 | 1.02 | 1.38 |
| Structural maintenance of chromosomes protein 4-like | Cell division | SMC4 | 1.83 | 1.99 | 1.66 | 1.48 | 1.55 | — | 1.07 | 1.85 | |
| Malignant fibrous histiocytoma-amplified sequence 1 homolog | Cell cycle arrest | MFHAS1 | 1.13 | 1.23 | 1.29 | 0.99 | 1.14 | 1.17 | 0.95 | 1.02 | 1.36 |
| Receptor activity-modifying protein 1-like | Ion transport | RAMP1 | 0.99 | 1.19 | 1.14 | 1.06 | 1.04 | 1.08 | 1.02 | — | 1.17 |
| Peptidylglycine alpha-amidating monooxygenase_106571984 | Peptide amidation | PAM | 1.16 | 1.19 | 1.12 | 1.01 | 1.04 | 1.15 | 1.01 | 1.03 | 1.22 |
| protein family with sequence similarity 214, A | Cell division | FAM214A | 1.21 | 1.34 | 1.19 | 0.98 | 1.05 | 1.18 | 1.01 | 0.98 | 1.12 |
| Calphotin | Cellular calcium regulation | Calphotin | 1.10 | 1.21 | 1.18 | 0.99 | 1.03 | 1.12 | 1.01 | 1.00 | 1.48 |
| Gutathione peroxidase 3 | Oxidative stress | GPX3 | 1.25 | 1.16 | 1.11 | 1.08 | 1.05 | 1.20 | 0.85 | 0.92 | 1.21 |
| Endothelin-converting enzyme 2 | Neuropeptide processing | ECE-2 | 1.16 | 1.25 | 1.20 | 1.10 | 1.09 | 1.20 | 1.04 | 1.02 | 1.38 |
| Cyclin dependent kinase inhibitor 1B | Cell cycle arrest | CDKN1B | 1.23 | 1.31 | 1.20 | 1.07 | 1.07 | 1.21 | 1.04 | — | 1.38 |
| Transcription factor SOX-5 | Cell cycle arrest | SOX-5 | 1.04 | 1.12 | 1.42 | 1.17 | 0.98 | 1.10 | 1.01 | 1.01 | 1.43 |
| Acyl-coenzyme A thioesterase 9, mitochondrial | Oxidative stress | ACOT9 | 1.13 | 1.25 | 1.45 | 1.15 | 1.07 | 1.27 | 1.01 | 1.01 | 1.37 |
Figure 4Validating RNA-seq platform with qRT-PCR data using the same 24 samples used in RNA-seq. Fold changes of gene expression detected by RNA-seq were plotted against the data of qRT-PCR. The reference line indicates the linear relationship between the results of RNA-seq and qRT-PCR.
Figure 5Canonical plots of the first two principal components of the identified hypoxia biomarkers using the 7 hypoxia biomarkers returned by the Shrunken Centroid method on significant correlated genes between RNA-seq and qRT-PCR platforms for 24 samples used in RNA-seq analysis. Temperature treatment symbols are 10 and 18 °C groups. Principal component analysis was performed on the training set (left panel) and then applied to the testing set (right panel). Centroids are represented by the largest point of the same color. Arrows represent loading vectors of the biomarkers using the training set.
Classification ability of the normoxia and hypoxia groups for 24 samples used in RNA-seq, and across the smoltification process of Chinook salmon, and the distressed (moribund/recently dead) fish using the hypoxia biomarkers. Biomarkers identified by Shrunken Centroid method for each group were placed into a linear discriminant analysis (LDA) for classifying groups within each treatment and mortality. LDA training set used two-thirds of the entire dataset. Presented are the classifications on the remaining one-third testing set. Columns are the LDA classification groups and rows are the real group. Salinity symbols are FW for freshwater, BW for brackish, and SW for seawater groups. Dissolved oxygen symbols are N for normoxia and H for hypoxia groups. Fish size (mean ± SD) symbols are L for length and W for weight
| Treatment | Sample size | Fish size | LDA Classification ability (%) | Significant genes identified by Shrunken analysis | Function of genes | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Training | Testing | L (cm) | W (g) | N | H | Average | |||||
| N | H | N | H | ||||||||
| RNA-seq samples | 16 | 8 | 8.4 ± 1.2 | 8.7 ± 1.4 | 6.5 ± 3.0 | 7.1 ± 3.4 | 100.0 | 75.0 | 87.5 | Claspin, Tonsl, ARHGAP11A, KIF2C, AURKB, ERCC6L | DNA synthesis, cell division, and cell cycle |
| RAMP1 | Ion transport | ||||||||||
| FW | 14 | 7 | 5.2 ± 0.4 | 5.2 ± 0.3 | 1.5 ± 0.3 | 1.5 ± 0.2 | 66.7 | 75.0 | 70.8 | Ndc80, Kif4, Anillin, Ncapd3 | DNA synthesis, cell division, and cell cycle |
| BW | 12 | 6 | 5.2 ± 0.3 | 5.2 ± 0.3 | 1.5 ± 0.2 | 1.4 ± 0.2 | 66.7 | 66.7 | 66.7 | Tonsl, NCAPG2, Anillin, KIF2C, CIT, Claspin, PCNA, Rab9, Lmnb1 | DNA synthesis, cell division, and cell cycle |
| SOX.5 | Cell cycle arrest | ||||||||||
| ACOT9 | Oxidative stress | ||||||||||
| SW | 13 | 6 | 5.2 ± 0.3 | 5.1 ± 0.3 | 1.7 ± 0.3 | 1.4 ± 0.2 | 75.0 | 100.0 | 87.5 | Kif15, Anillin | DNA synthesis, cell division, and cell cycle |
| CDKN1B | Cell cycle arrest | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| GPX3 | Oxidative stress | ||||||||||
| PAM | Peptide amidation | ||||||||||
| FW | 14 | 8 | 7.6 ± 0.4 | 7.2 ± 0.3 | 4.6 ± 0.8 | 4.1 ± 0.6 | 75.0 | 75.0 | 75.0 | PCNA, Rab9, Kif4, Claspin, Ncapd3, Ndc80 | DNA synthesis, cell division, and cell cycle |
| SOX.5 | Cell cycle arrest | ||||||||||
| GPX3 | Oxidative s tress | ||||||||||
| ECE.2 | Neuropeptide processing | ||||||||||
| BW | 12 | 6 | 7.5 ± 0.5 | 7.5 ± 0.4 | 4.6 ± 1.0 | 4.6 ± 0.8 | 100.0 | 33.0 | 66.7 | Lmnb1, FAM214A | DNA synthesis, cell division, and cell cycle |
| CDKN1B | Cell cycle arrest | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| SW | 12 | 6 | 7.6 ± 0.2 | 7.5 ± 0.5 | 4.7 ± 0.6 | 4.6 ± 1.0 | 66.7 | 100.0 | 83.3 | Anillin, H2AFV, RRM1 | DNA synthesis, cell division, and cell cycle |
| CDKN1B | Cell cycle arrest | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| FW | 12 | 6 | 9.5 ± 0.9 | 9.0 ± 1.3 | 9.0 ± 2.7 | 7.7 ± 2.8 | 66.7 | 100.0 | 83.3 | Ndc80, Kif4, Anillin, ARHGAP11A, KIF2C, AURKB | DNA synthesis, cell division, and cell cycle |
| BW | 20 | 10 | 9.5 ± 1.1 | 8.9 ± 1.0 | 7.8 ± 2.7 | 7.5 ± 2.6 | 40.0 | 60.0 | 50.0 | FAM214A | DNA synthesis, cell division, and cell cycle |
| ACOT9 | Oxidative stress | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| SW | 31 | 16 | 7.6 ± 1.2 | 8.5 ± 1.0 | 6.8 ± 2.8 | 6.6 ± 2.4 | 100.0 | 75.0 | 87.5 | Claspin, RRM1, Tonsl, FAM214A, Anillin, Rab9, CIT, Lmnb1 | DNA synthesis, cell division, and cell cycle |
| CDKN1B, SOX.5, MFHAS1 | Cell cycle arrest | ||||||||||
| Calphotin | Cellular calcium regulation | ||||||||||
| GPX3, ACOT9 | Oxidative stress | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| FW | 17 | 9 | 8.3 ± 0.9 | 8.0 ± 1.0 | 6.1 ± 2.1 | 5.5 ± 2.2 | 80.0 | 100.0 | 90.0 | KIF2C | Cell division and DNA synthesis |
| MFHAS1 | Cell cycle arrest | ||||||||||
| GPX3 | Oxidative stress | ||||||||||
| ECE.2 | Neuropeptide processing | ||||||||||
| SW | 34 | 17 | 7.3 ± 1.8 | 6.7 ± 1.7 | 4.4 ± 2.9 | 3.4 ± 2.3 | 77.8 | 100.0 | 88.9 | FAM214A, Kif4, ARHGAP11A, H2AFV, Claspin, Kif15 | Cell division and DNA synthesis |
| SOX.5, MFHAS1, CDKN1B | Cell cycle arrest | ||||||||||
| GPX3, ACOT9 | Oxidative stress | ||||||||||
| ECE.2 | Neuropeptide processing | ||||||||||
| RAMP1 | Ion transport | ||||||||||
| PAM | Peptide amidation | ||||||||||
Figure 6Canonical plots of the first two principal components using 8 hypoxia biomarkers returned by the Shrunken Centroid method for the extreme hypoxia group of SW/18°C in trial 3. 11 live individuals exposed to extreme hypoxia for approximately two days (SW18_exH_L), 11 dead or moribund individuals exposed to extreme hypoxia (SW18_exH_D), 11 live fish kept in normal oxygen for six days (SW18N), and 11 live individuals exposed to designed hypoxia for six days (SW18H). Principal component analysis was performed on the training set (left panel) and then applied to the testing set (right panel). Centroids are represented by the largest point of the same color. Arrows represent loading vectors of the biomarkers using the training set.